September 11 forces delays to FDA inspections
This article was originally published in Clinica
Executive Summary
The US FDA expects to see a sharp decline in the percentage of manufacturing plants it inspected this year as a result of the events surrounding last September's terrorist bombing of the World Trade Center in New York.